Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Acura Pharmaceuticals Cash from Operations (TTM): -0.396M for Sept. 30, 2021
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.742M |
| September 30, 2021 | -0.396M |
| June 30, 2021 | -1.132M |
| March 31, 2021 | -1.379M |
| December 31, 2020 | -0.719M |
| September 30, 2020 | -0.117M |
| June 30, 2020 | 1.028M |
| March 31, 2020 | 0.128M |
| December 31, 2019 | -0.618M |
| September 30, 2019 | -2.363M |
| June 30, 2019 | -3.714M |
| March 31, 2019 | -3.342M |
| December 31, 2018 | -3.908M |
| September 30, 2018 | -4.307M |
| June 30, 2018 | -5.655M |
| March 31, 2018 | -6.773M |
| December 31, 2017 | -4.51M |
| September 30, 2017 | -1.108M |
| June 30, 2017 | -0.867M |
| March 31, 2017 | -2.343M |
| December 31, 2016 | -5.563M |
| September 30, 2016 | -8.399M |
| June 30, 2016 | -8.67M |
| March 31, 2016 | -7.777M |
| December 31, 2015 | -3.688M |
| Date | Value |
|---|---|
| September 30, 2015 | -4.991M |
| June 30, 2015 | -5.494M |
| March 31, 2015 | -5.897M |
| December 31, 2014 | -11.04M |
| September 30, 2014 | -11.85M |
| June 30, 2014 | -12.33M |
| March 31, 2014 | -13.34M |
| December 31, 2013 | -13.68M |
| September 30, 2013 | -12.35M |
| June 30, 2013 | -11.06M |
| March 31, 2013 | -8.985M |
| December 31, 2012 | -7.038M |
| September 30, 2012 | -7.089M |
| June 30, 2012 | -7.109M |
| March 31, 2012 | 12.50M |
| December 31, 2011 | 12.31M |
| September 30, 2011 | 12.38M |
| June 30, 2011 | 13.10M |
| March 31, 2011 | -5.241M |
| December 31, 2010 | -6.48M |
| September 30, 2010 | -7.37M |
| June 30, 2010 | -8.472M |
| March 31, 2010 | -9.609M |
| December 31, 2009 | -5.203M |
| September 30, 2009 | -2.983M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-3.714M
Minimum
Jun 2019
1.028M
Maximum
Jun 2020
-0.9113M
Average
-0.719M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |